Goodman Advisory Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474K Sell
7,544
-11,944
-61% -$832K 0.12% 67
2025
Q4
$1.29M Buy
+19,488
New +$1.26M 0.32% 43

Other funds holding DXCM

Goodman Advisory Group's DXCM Position: Q1 2026 in Review

Goodman Advisory Group reduced its DexCom (DXCM) stake by 61% in Q1 2026, selling an estimated $832K and leaving 7,544 shares worth $474K. The position accounts for 0.12% of the portfolio, ranked #67.

Goodman Advisory Group first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.29M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Goodman Advisory Group held 7,544 shares of DexCom worth $474K as of Q1 2026.
  • Goodman Advisory Group sold 11,944 DexCom shares in Q1 2026, an estimated $832K.
  • DexCom made up 0.12% of Goodman Advisory Group's portfolio in Q1 2026, its #67 holding.
  • Goodman Advisory Group first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
  • Goodman Advisory Group's DexCom position peaked at $1.29M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Goodman Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.